{"id":"ccf279a5-7646-5da8-ad37-c5d5376490ba","stable_key":"7de430a5-1a36-5231-b931-35cc01d8f3bf:apap-seven-in-eighty-three","predicate":"causes","statement":"Of 237 challenges with various non-steroidal anti-inflammatory drugs and paracetamol in 101 intolerant patients, 19 challenges were positive and 2 patients developed anaphylactic shock, with a ratio of positive to total challenges of 7 of 83 for paracetamol, 2 of 49 for imidazole-hydroxybenzoate and 0 of 30 for nimesulide, and the authors conclude that a positive history of intolerance to a given drug is sufficient reason to contraindicate its use even for diagnostic challenge, which should be restricted to assessing tolerability of alternatives.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"c7addd31-037a-5746-be73-b0c2581e142c","mechanism_event_label":"About one in twelve challenges with paracetamol was positive in people already intolerant of these drugs.","subject":{"id":"a901be21-7915-543c-ac67-c39ef72b0d03","slug":"acetaminophen","display_name":"Paracetamol","entity_type_key":"drug"},"object":{"id":"5643975a-0dd2-5860-8c67-eeae0d9e53d1","slug":"urticaria-angioedema","display_name":"Urticaria and angioedema","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"c7addd31-037a-5746-be73-b0c2581e142c","stable_key":"7de430a5-1a36-5231-b931-35cc01d8f3bf:apap-seven-in-eighty-three-event","event_type":"observed_intervention","label":"About one in twelve challenges with paracetamol was positive in people already intolerant of these drugs.","description":"Of 237 challenges with various non-steroidal anti-inflammatory drugs and paracetamol in 101 intolerant patients, 19 challenges were positive and 2 patients developed anaphylactic shock, with a ratio of positive to total challenges of 7 of 83 for paracetamol, 2 of 49 for imidazole-hydroxybenzoate and 0 of 30 for nimesulide, and the authors conclude that a positive history of intolerance to a given drug is sufficient reason to contraindicate its use even for diagnostic challenge, which should be restricted to assessing tolerability of alternatives.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"3f745fea-645b-5b10-8a9a-989940e5b826","slug":"aspirin-sensitive-subject","display_name":"Subject with aspirin-sensitive asthma or aspirin-induced urticaria","entity_type_key":"cellular_process"},"role":"studied_group","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"14938ba1-ca17-5b4e-8d88-0fef729dbcc1","slug":"dipyrone","display_name":"Dipyrone / metamizole","entity_type_key":"drug"},"role":"co_challenged_drug","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"d7a404d3-86ed-532b-9333-3d8c5ce60135","slug":"nimesulide","display_name":"Nimesulide","entity_type_key":"drug"},"role":"co_challenged_drug","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"a901be21-7915-543c-ac67-c39ef72b0d03","slug":"acetaminophen","display_name":"Paracetamol","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"5643975a-0dd2-5860-8c67-eeae0d9e53d1","slug":"urticaria-angioedema","display_name":"Urticaria and angioedema","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/paracetamol-research/7506185.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"b38b08631ecb8137b8297b631b8dab0a4378d5445e29c557e3586b546e0e874f\", \"start_char\": 0, \"end_char\": 1590, \"text_sha256\": \"b38b08631ecb8137b8297b631b8dab0a4378d5445e29c557e3586b546e0e874f\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Oral challenge series in 112 and then 284 patients intolerant of non-steroidal anti-inflammatory drugs","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Challenges with aspirin, dipyrone, paracetamol, imidazole-hydroxybenzoate and nimesulide","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Provides the denominator that the case reports lack, and records two anaphylactic shocks during challenge, which is why the authors restrict the procedure.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404.","comparator":null,"unit":null,"notes":"","entity":{"slug":"acetaminophen","display_name":"Paracetamol","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"About one in twelve challenges with paracetamol was positive in people already intolerant of these drugs.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[apap-p7506185] Oral challenge with alternative nonsteroidal antiinflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. (1993). https://pubmed.ncbi.nlm.nih.gov/7506185/ DOI: 10.2165/00003495-199300461-00065","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Whole body","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"130cb2ed-f283-57ff-adb4-558cadbc2086","evidence_kind":"source_excerpt","locator":"Lines 480-491","start_line":480,"end_line":491,"excerpt":"### apap-seven-in-eighty-three\nOf 237 challenges with various non-steroidal anti-inflammatory drugs and paracetamol in 101 intolerant patients, 19 challenges were positive and 2 patients developed anaphylactic shock, with a ratio of positive to total challenges of 7 of 83 for paracetamol, 2 of 49 for imidazole-hydroxybenzoate and 0 of 30 for nimesulide, and the authors conclude that a positive history of intolerance to a given drug is sufficient reason to contraindicate its use even for diagnostic challenge, which should be restricted to assessing tolerability of alternatives.\nCondition category: normal\nnutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404.\nplain_language: About one in twelve challenges with paracetamol was positive in people already intolerant of these drugs.\norganism: Human\ntissue_or_cell_type: Whole body\nexperimental_model: Oral challenge series in 112 and then 284 patients intolerant of non-steroidal anti-inflammatory drugs\nlimitations: Provides the denominator that the case reports lack, and records two anaphylactic shocks during challenge, which is why the authors restrict the procedure.\nexposure: Challenges with aspirin, dipyrone, paracetamol, imidazole-hydroxybenzoate and nimesulide\nevidence_span: {\"source_cache\": \"artifacts/paracetamol-research/7506185.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"b38b08631ecb8137b8297b631b8dab0a4378d5445e29c557e3586b546e0e874f\", \"start_char\": 0, \"end_char\": 1590, \"text_sha256\": \"b38b08631ecb8137b8297b631b8dab0a4378d5445e29c557e3586b546e0e874f\"}\n[apap-p7506185] Oral challenge with alternative nonsteroidal antiinflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. (1993). https://pubmed.ncbi.nlm.nih.gov/7506185/ DOI: 10.2165/00003495-199300461-00065","model_system":"Oral challenge series in 112 and then 284 patients intolerant of non-steroidal anti-inflammatory drugs","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [apap-p7506185] Oral challenge with alternative nonsteroidal antiinflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. (1993). https://pubmed.ncbi.nlm.nih.gov/7506185/ DOI: 10.2165/00003495-199300461-00065","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"9ee11177-f860-5877-bb82-f4ee4acdc538","stable_key":"import-7de430a5-1a36-5231-b931-35cc01d8f3bf","title":"Paracetamol: the enzyme it reduces rather than blocks, the isoform that turned out not to exist, the metabolite that carries the analgesia, and the metabolite that destroys the liver (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"9c145887aa10fa7b85f54712e0b41fd9e04fb9544d3182793dd84414dbf8c2ae","revision_id":"c3e7827a-4f10-55e0-97b9-5782b044f7cc","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}